AAD: new results from Sanofi's amlitelimab phase 3 studies in atopic dermatitis presented in late-breaking research session Across the COAST 1, COAST 2, and SHORE phase 3 studies, amlitelimab, dosed ...
The South African is an English-language South African online news publication and a leading source for news, sport, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results